The RTG 'vivid' focuses on the comprehensive analysis of early factors in type 2 diabetes development.
About 7 million people in Germany suffer from type 2 diabetes mellitus (T2DM). Genetic predisposition and environmental factors, in particular early exposure to adverse modifiable lifestyle factors such as prenatal or juvenile overnutrition and lack of exercise have been associated with an increased diabetes risk. However, the mechanistic links between early exposures, onset of impaired insulin action in early life and inadequate β−cell function in subsequent phases are not well understood.
The aim of the research program is to better understand the critical molecular mechanisms in the early development of T2DM. Doctoral researchers in basic sciences and medicine (PhD/MD) will jointly investigate novel experimental models for early diabetes development. A structured and coherent qualification program sets the frame for sustained training and mentoring to gain comprehensive knowledge in translational diabetes research.
See further details for research projects and open positions. Next scholarships for doctoral MD students are available in April 2022.
Fragen zum Programm und Doktorandenstellen?
Jeden ersten Mittwoch im Monat um 18:00 Uhr stehen wir für Fragen rund um das Graduiertenkolleg zur Verfügung.
Zugang via Skype:
Dr. Nicole Rockel
+49 211 3382 558 German Diabetes Center
Leibniz Center for Diabetes Research at HHU
Auf´m Hennekamp 65
Office Hours: Mo. - Thur. 10 a.m - 3 p.m.